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Loss of metabolic homeostasis is a hallmark of aging
and is commonly characterized by the deregulation
of adaptive signaling interactions that coordinate
energy metabolism with dietary changes. The mech-
anisms driving age-related changes in these adap-
tive responses remain unclear. Here, we characterize
the deregulation of an adaptive metabolic response
and the development of metabolic dysfunction in
the aging intestine ofDrosophila. We find that activa-
tion of the insulin-responsive transcription factor
Foxo in intestinal enterocytes is required to inhibit
the expression of evolutionarily conserved lipases
as part of a metabolic response to dietary changes.
This adaptive mechanism becomes chronically acti-
vated in the aging intestine, mediated by changes
in Jun-N-terminal kinase (JNK) signaling. Age-related
chronic JNK/Foxo activation in enterocytes is delete-
rious, leading to sustained repression of intestinal
lipase expression and the disruption of lipid homeo-
stasis. Changes in the regulation of Foxo-mediated
adaptive responses thus contribute to the age-asso-
ciated breakdown of metabolic homeostasis.
INTRODUCTION
Insulin/Insulin Growth Factor Signaling/Foxo Function
and Metabolic Adaptation
In complex organisms, adaptation to changing dietary condi-
tions is critical to maintain metabolic homeostasis (Luca et al.,
2010; Roberts and Rosenberg, 2006). Adaptation has to occur
at multiple levels and involves adjusting processes that control
nutrient uptake, storage, and usage to dietary changes in order
to properly maintain energy homeostasis (Roberts and Rosen-
berg, 2006). It has been proposed that modern (high-sugar/
high-fat) diets can lead to misregulation of evolutionarily
conserved adaptive dietary responses, resulting in metabolic
dysfunction (Odegaard and Chawla, 2013). Furthermore, the1250 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The Auage-associated decline of the ability to metabolically adapt to
dietary changes is a likely cause for the increased incidence of
metabolic diseases in the elderly (Roberts and Rosenberg,
2006). Our understanding of the mechanisms causing diet-
induced or age-related changes in metabolic adaptive re-
sponses remains limited, and studies in model organisms are
likely to provide critical insight into such mechanisms and into
potential strategies for therapeutic or preventive interventions.
Insulin/insulin growth factor (IGF) signaling (IIS) is one of the
best understood signaling systems involved in metabolic adap-
tation and the control of metabolic homeostasis. In multicellular
organisms, IIS governs energy homeostasis by regulating lipid
and carbohydrate metabolism (Saltiel and Kahn, 2001), pro-
motes cell growth and proliferation (Accili and Arden, 2004;
Oldham and Hafen, 2003), and influences systemic stress
responses (Baumeister et al., 2006; Karpac et al., 2009, 2011;
Niedernhofer et al., 2006; van der Pluijm et al., 2007). Its central
role in these processes is highlighted by the fact that attenuating
IIS function in invertebrates and vertebrates can extend lifespan
(Barzilai et al., 2012; Karpac and Jasper, 2009; Taguchi and
White, 2008; Tatar et al., 2003). The transcription factor Foxo,
activated in response to decreased IIS activity, is an essential
mediator of this lifespan extension (Lin et al., 1997; Ogg et al.,
1997; Slack et al., 2011). Foxo regulates a battery of stress
response and metabolic control genes (Calnan and Brunet,
2008; Matsumoto and Accili, 2005), and its activation has selec-
tive tissue-specific consequences. Thus, activating Foxo in the
intestine of worms or in the adipose tissue and muscle of flies
can extend lifespan (Demontis and Perrimon, 2010; Giannakou
et al., 2004; Hwangbo et al., 2004; Libina et al., 2003; Zhang
et al., 2013), whereas activation in other tissues and cell-types
can reduce lifespan or promote cell death (Biteau et al., 2010;
Luo et al., 2007).
In mammals, loss of the insulin receptor in adipose tissue can
have positive effects on lifespan (Blu¨her et al., 2003), whereas IIS
inhibition and Foxo activation in other tissues (such as liver,
brain, and muscle) contributes to metabolic and degenerative
diseases (Kido et al., 2000; Michael et al., 2000; Mihaylova
et al., 2011; Suzuki et al., 2010). Importantly, many age-related
metabolic pathologies are associated with chronic insulin resis-
tance in humans (Barzilai et al., 2012). In these conditions, Foxothors
contributes to the breakdown of lipid and glucose homeostasis,
promoting diabetes (Eijkelenboom and Burgering, 2013; Samuel
and Shulman, 2012).
Importantly, Foxo can be activated independently by stress
signaling pathways, in particular Jun-N-terminal Kinase (JNK)
signaling, which responds to a variety of inflammatory and
stress signals and is a major contributor to insulin resistance
but can also increase lifespan in worms and flies (Biteau et al.,
2011b; Hirosumi et al., 2002; Karpac and Jasper, 2009; Samuel
and Shulman, 2012). The integration of nutritional responses
through IIS with JNK-mediated stress signals by Foxo thus likely
determines the beneficial or pathological consequences of
attenuated insulin signaling.
IIS/Foxo and the Regulation of Lipid Metabolism
Many of the metabolic consequences of altered IIS and Foxo
signaling are caused by changes in glucose and lipid meta-
bolism. The role of IIS in regulating systemic glucose homeosta-
sis and the function of Foxo in promoting glycogenolysis and
gluconeogenesis in various tissues are well understood (Accili
and Arden, 2004; Eijkelenboom and Burgering, 2013; Saltiel
and Kahn, 2001; Samuel and Shulman, 2012). At the same
time, altered IIS activity is also associated with abnormal lipid
metabolism. Mice and flies in which IIS has been genetically
manipulated have disrupted lipid metabolism (Kitamura et al.,
2003; Teleman, 2010), yet the cell and tissue-specific mecha-
nisms by which IIS regulates lipid metabolism are only partially
understood. In both Drosophila and mammals, Foxo regulates
the transcription of lipases in adipose tissue required for the
lipolysis of stored lipids (Chakrabarti and Kandror, 2009; Viher-
vaara and Puig, 2008; Wang et al., 2011), as well as the expres-
sion of enzymes and other transcription factors involved in lipid
catabolism (Deng et al., 2012; Xu et al., 2012). Regulation of
Foxo thus provides a mechanism by which insulin can regulate
lipid metabolism during metabolic adaptation. Changes in IIS/
Foxo-regulated lipases (such as adipose triglyceride lipase)
and lipogenic transcription factors (such as SREBP-1c) have
been linked to the dyslipidemia associated with type 2 diabetes
and other metabolic syndromes (Badin et al., 2011; Schoenborn
et al., 2006; Shimomura et al., 2000).
The Drosophila intestine is rapidly becoming a productive
model system in which to study complex questions relating to
the maintenance of tissue function, immune responses, meta-
bolic homeostasis, and stress signaling. Importantly, the intes-
tine is key to the control of lipid and cholesterol homeostasis
in the fly (Sieber and Thummel, 2012). Disruption of gut entero-
cyte function (cells required for nutrient uptake and innate
immune function within the intestinal epithelium) can lead to
organism-wide changes in lipid metabolism (Sieber and Thum-
mel, 2009). Furthermore, as a critical barrier epithelium, the
age-related dysfunction of this tissue significantly limits health-
and lifespan of flies (Biteau et al., 2010; Rera et al., 2012,
2013). The adult intestine is regenerated by intestinal stem cells
(ISCs), which divide to replace enterocytes (ECs) and enteroen-
docrine cells when needed (Biteau et al., 2011a; Micchelli and
Perrimon, 2006; Ohlstein and Spradling, 2006). Previous studies
have shown that ISCs hyperproliferate in the aging gut, resulting
in loss of tissue homeostasis and the development of a generalCell Reinflammatory condition characterized by excessive oxidative
stress and chronic JNK activation (Biteau et al., 2008, 2010;
Buchon et al., 2009; Choi et al., 2008; Rera et al., 2012). We
have recently shown that the regenerative capacity of stem cells
strongly influences lifespan in Drosophila and that improving
intestinal tissue homeostasis also rescues the age-dependent
systemic breakdown of lipid homeostasis (Biteau et al., 2010).
Here, we identify a mechanism by which Foxo activity in the
intestinal epithelium regulates metabolic adaptation to dietary
changes in Drosophila. We show that Foxo activity in the
intestine is required to inhibit the expression of evolutionarily
conserved lipases as part of an adaptive metabolic response
to changes in dietary protein/lipids. On a standard diet, Foxo-
mediated repression of these lipases is required to prevent
excessive lipid uptake, thus promoting systemic metabolic
homeostasis. Strikingly, we find that this regulatory mechanism
is constitutively activated in aging animals, contributing to meta-
bolic imbalances and the age-associated breakdown of lipid
homeostasis. This activation is caused by chronic activation of
JNK and reflects the development of a general inflammatory
condition in the aging gut. Our findings define a distinct case in
which an adaptive mechanism promoting metabolic homeosta-
sis is deregulated by an age-associated increase in stress
signaling, thus contributing to the breakdown of metabolic
homeostasis.
RESULTS
Foxo-Mediated Regulation of Intestinal Lipid
Metabolism
To explore potential mechanisms within the gut that could
mediate IIS-dependent adaptive responses to changes in
nutrient availability and therefore promote metabolic homeo-
stasis, we focused on the response of the Drosophila intestine
to a dietary shift from a standard yeast/sugar-based (St. SY)
diet to an isocaloric high-sugar/low-yeast (HSLY) diet. The
HSLY diet greatly reduces the amount of dietary protein and
lipids while maintaining calories through excessive carbohy-
drates (Skorupa et al., 2008). HSLY diet feeding leads to the
transcriptional downregulation of insulin ligands dilp2 and dilp5
(Figure 1A). These insulin-like peptides are secreted by neurose-
cretory insulin-producing cells in the brain and have previously
been described as responsive to nutrient imbalance (Garofalo,
2002; Ge´minard et al., 2009; Rulifson et al., 2002). This repres-
sion of dilp transcription is sufficient to systemically attenuate
IIS activity in the gut, as HSLY diet feeding results in decreases
in peripheral phospho-Akt (p-Akt) levels (Figure 1B). Total Akt
levels are also reduced in the intestine during HSLY diet feeding
(Figure 1B). This suggests that other insulin-independent feed-
back mechanisms might also contribute to changes in Akt activ-
ity under these dietary conditions. The decrease in Akt/p-Akt
levels was accompanied by the activation of Foxo target genes
(evidenced by increased expression of lacZ from a thor [4E-
BP] promoter [thor-lacZ]; Figure 1C) in the intestine, confirming
that IIS-dependent signaling is suppressed in this tissue.
To assess whether the decrease in dietary lipids and proteins
in the HSLY diet influences the expression of genes involved in
metabolic adaptation to dietary changes, we measured theports 4, 1250–1261, September 26, 2013 ª2013 The Authors 1251
Figure 1. Foxo-Mediated Regulation of lipA/
magro Expression in Response to Dietary
Changes
(A) dlip2 and dlip5 transcription (from dissected
heads) and lipA/magro transcription (from
dissected intestines) measured by qRT-PCR in
wild-type flies (adult OreR females) under various
dietary feeding conditions. Flies were 5–7 days old
when switched to either a St. SY or HSLY for
5 days. All subsequent experiments shown in this
figure represent 5 days after St. SY or HSLY diet
feeding in female flies.
(B) Western blot analysis of p-Akt and total Akt
(Akt) levels in dissected intestines from OreR flies
after St. SY or HSLY diet feeding. Levels of b-actin
serve as a loading control.
(C) X-gal staining of dissected intestines (image
shows posterior midgut) after St. SY or HSLY diet
feeding in thor-LacZ flies.
(D and E) Repression of lipA/magro transcription
(measured by qRT-PCR) during HSLY diet feeding
is blocked when Foxo is inhibited in (D) intestinal
enterocytes (NP1G4/UAS-FoxoRNAi compared to
controls [NP1G4/+(yw)]; RNA collected from
dissected intestines) and (E) in Foxo mutant
animals (foxoW24/foxoW24 compared to yw con-
trols; RNA collected from whole flies).
Bars represent mean ± SE; *p < 0.05 and **p <
0.005; and n = 4–6 samples.
See also Figures S1, S2, S3, and Table S2.expression of lipA/magro, a gene that encodes an intestine-
specific lipase with a described role in fat and cholesterol
absorption in the gut (Sieber and Thummel, 2009, 2012). Magro
(LipA in mammals) is expressed in distinct set of enterocytes in
the adult fly intestine (Figure S1A) and is secreted into the intes-
tinal lumen to digest dietary triacylglycerol (TAG) (Sieber and
Thummel, 2012). Strikingly, the HSLY diet results in strong
repression of lipA/magro in the intestine (Figure 1A), whereas
refeeding flies a St. SY diet after 5 days on a HSLY diet could
normalize their expression (Figure 1A), suggesting that the tran-
scriptional regulation of this lipase is part of an adaptive
response to dietary changes.
To determine if changes in IIS/Foxo activity are responsible
for this response, we further monitored the expression of
lipA/magro in various Foxo loss-of-function genetic back-
grounds. Reducing Foxo activity in intestinal enterocytes
(using the NP1Gal4 driver [Figure S1B] and upstream acti-
vating sequence [UAS]-Foxo RNAi [Figures S2A–S2C]) pre-
vented the downregulation of lipA/magro expression during
HSLY diet feeding (Figure 1D), suggesting that Foxo activity1252 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The Authorsis required for the transcriptional
repression of this lipase. This notion was
confirmed in flies homozygous for the
foxo null allele foxoW24, which also
showed a significant increase in lipA/
magro expression under fed conditions
(Figure 1E; additional allele [foxoD94]
shown in Figure S2D). However, it re-
mains unclear how changes in Foxoactivation and lipA/magro expression affect intestinal lipid
metabolism during HSLY diet feeding.
The regulation of lipA/magro by Foxo suggests that Foxo-
mediated responses to dietary changes are critical for metabolic
adaptation and the control of lipid homeostasis. To test this
hypothesis, we temporally manipulated Foxo activity in intestinal
enterocytes using an adult-onset driver. To prevent develop-
mental effects of the expression of UAS-driven transgenes, we
used a heat-inducible system, in which NP1Gal4 is combined
with a temperature-sensitive Gal80 (TARGET system [Oster-
walder et al., 2001]). Reducing Foxo activity (using UAS-Foxo
RNAi) in enterocytes for 5 days leads to upregulation of intestinal
lipA/magro expression (Figure 2A). This correlates with a signifi-
cant increase (28%) in stored TAG levels in thewhole animal (Fig-
ures 2A and S3D). Elevated TAG levels are not due to changes in
feeding behavior, as inhibiting Foxo function in enterocytes does
not lead to significant changes in activity/rhythmicity or food
intake (Figures S3A–S3C). These data suggest that Foxo is
required in enterocytes to limit intestinal lipase expression and
maintain lipid homeostasis in the organism. Conversely, chronic
Figure 2. Foxo-Dependent Regulation of In-
testinal Lipid Metabolism
(A) Elevated lipA/magro transcription (measured
by qRT-PCR in dissected intestines) and TAG
levels (from whole animals) when Foxo is
conditionally knocked down in intestinal enter-
ocytes (NP1G4,tubG80ts/UAS-FoxoRNAi com-
pared to NP1G4,tubG80ts/+ [yw] controls). Five- to
seven-day-old adult females were placed at 29C
for 5 days to induce conditional expression of
transgenes for all experiments represented in
this figure.
(B) Repression of lipA/magro transcription when
Foxo is overexpressed in enterocytes (NP1G4,
tubG80ts/UAS-Foxo compared to NP1G4,
tubG80ts/+ [w1118] controls, 5 days at 29C).
(C and C0 ) Oil red O (ORO) staining of dissected
intestines shows reduced lipid accumulation
(image shows anterior midgut) in enterocyte-
specific Foxo gain-of-function conditions. ORO
intensity measurements represent mean ± SE of
ten guts.
(D and E) Lipolytic activity from intestinal lysates
(measured as the release of glycerol from a lipid
emulsion) (D) and whole animal TAG levels (E) are
also decreased.
(F) After 5 days at 29C to induce Foxo expression,
female flies were subjected to wet starvation at
25C. Results are represented as percent survival
(mean ± SE) of six cohorts of 17–20 flies form
individual populations. Similar results were ob-
tained with male flies.
Bars represent mean ± SE and n = 4–6 samples.
See also Figures S2, S3, S4, and Table S2.overexpression of wild-type Foxo in intestinal enterocytes
strongly represses lipA/magro transcription and disrupts intesti-
nal lipid storage (Figures 2B–2C0). Importantly, intestinal over-
expression of Foxo induces thor expression but does not lead
to the disruption of epithelial morphology (Figures S4A and
S4B), showing that these effects are truly a response to Foxo
activity in enterocytes and not due to global tissue degeneration.
This downregulation of intestinal lipase transcription correlates
with a reduction in intestinal lipolytic activity (Figure 2D) and a
strong decrease (nearly 50%) in stored lipid levels in the whole
organism (Figures 2E and S3D). Furthermore, flies with chronicCell Reports 4, 1250–1261, Sepintestinal Foxo activation are extremely
sensitive to starvation, confirming a
breakdown of lipid homeostasis in these
animals (Figures 2F and S3E). Overex-
pression of Foxo in enterocytes does
lead to a small but significant decrease
in food intake (Figure S3C). Further
studies are needed to establish whether
this change in feeding behavior is a cause
or a consequence of the observed
decrease in intestinal lipase expression
and lipid storage. However, because
loss of Foxo in this tissue did not influence
feeding behavior, it is likely that the smallchange observed in Foxo gain-of-function conditions is a con-
sequence rather than a cause of tissue-specific metabolic
changes elicited by Foxo.
Taken together, these data show that Foxo can inhibit the
expression of intestinal lipases and therefore control organismal
lipid homeostasis through the regulation of intestinal lipid
metabolism.
Age-Related Disruption of Intestinal Lipid Metabolism
In a previous study, we found that an age-related decline in gut
function is associated with changes in lipid metabolism intember 26, 2013 ª2013 The Authors 1253
Figure 3. Age-Related Disruption of Intesti-
nal Lipid Metabolism
(A) SAGE analysis revealed several genes involved
in digestion (trypsins) and nutrient uptake (lipases)
downregulated in old (60 days) versus young
(5–7 days) intestines fromwild-type (OreR females)
flies. Numbers represent quantity of sequenced
tags in the individual libraries. See also Table S1.
(B–C0) lipA/magro and CG6295 transcription
measured by qRT-PCR (B) and ORO staining
(C and C0) in young (5–7 days) and old (35–45 days)
wild-type intestines. Whole gut images show large
region of stored lipid in anterior midgut of the adult
Drosophila intestine (black bar). ORO intensity
measurements represent mean ± SE of nine to ten
guts.
(D) Overexpressing LipA/Magro in intestinal en-
terocytes (NP1G4/UAS-Magro) significantly res-
cues the reduction of TAG levels in aged flies
compared to controls (NP1G4/+ [w1118]). TAG
levels weremeasured fromwhole animals in young
(5–7 days) and old (35 days) flies.
Bars represent mean ± SE and n = 4–8 samples.
See also Figures S3, S5, and Tables S1 and S2.Drosophila (Biteau et al., 2010). In genome-wide expression pro-
files generated from young and old guts of wild-type flies (using
serial analysis of gene expression [SAGE] in combination with
next-gen sequencing), we further found significant transcrip-
tional downregulation of trypsins (digestive serine proteases,
see also Biteau et al. [2008]) and of lipA/magro and CG6295
(confirmed by qRT-PCR; Figures 3A and 3B; also see Table
S1). CG6295 is another putative lipase that has over 30% amino
acid homology to mammalian pancreatic TAG lipase-related
proteins, which are gastric lipases important for fat absorption
in the intestine (Lowe, 2000). Importantly, the repression of these1254 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The Authorslipases is not dependent on the disruption
of intestinal epithelium structure (i.e., age-
related over-proliferation and misdiffer-
entiation of ISC’s leading to decreases
in functional enterocytes; Figure S5B),
as aged flies in which ISC’s have been
ablated (preventing the disruption of
epithelial structure) also show significant
lipA/magro downregulation in the intes-
tine (Figures S5A and S5B).
These results indicated that the dis-
ruption of systemic metabolic homeosta-
sis observed in aging animals might be
associated with a dysfunction of the
adaptive response to dietary changes
described above. Supporting this notion,
we found that the age-dependent rep-
ression of lipA/magro and CG62952
expression correlates with a reduction in
intestinal lipid storage, as evidenced by
oil red O (neutral lipid) staining (Figures
3C and 3C0). Furthermore, overex-
pression of LipA/Magro, specifically inintestinal enterocytes, can significantly rescue the age-related
reduction of TAG levels in whole animals (Figures 3D and S3C).
These data support a role for the deregulation of intestinal lipase
expression in the age-related disruption of lipid homeostasis.
Increased Foxo Activation in the Aging Intestine
Because we found that LipA/Magro can be regulated by Foxo
activity in the intestine, we tested whether aging modulates
Foxo activity in the gut and found that Foxo activity indeed signif-
icantly increases in the intestine as the animal ages. Foxo activa-
tion was measured using both the Foxo reporter thor-lacZ, as
well as by measuring the expression of the Foxo target genes
thor, InR (insulin receptor), and dlip4 (lipase 4) (Figures 4A and
4B). Intestinal activation of Foxo is first observed in a significant
number of flies at around 20 days of age and progressively
spreads through the population to reach around 85% at age
40 (Figure 4C). These data do not rule out that thor-lacZ induc-
tion could be invariant with age, but individuals without induction
die at younger ages and are eliminated from the population.
However, we did not observe significant changes in mortality
at 20 days of age (compared to 5-day-old flies; data not shown),
suggesting that the incidence of intestinal thor-lacZ induction
within a population of flies does increase with age. Immunohis-
tochemistry for b-Gal revealed that this age-related increase in
Foxo activity occurs specifically in intestinal enterocytes and
not in intestinal stem cells (marked by esgGal4 > UAS-GFP; Fig-
ure 4A). Furthermore, reducing Foxo activity in enterocytes was
sufficient to prevent the age-associated repression of lipA/
magro and CG6295 (Figures 5D and 5E). Elevated Foxo activity
in the aging gut thus contributes to the inhibition of intestinal
lipase expression.
To determine if this increase in Foxo activity and repression of
lipase transcription correlates with attenuation of IIS, similar to
the response to HSLY feeding, we assayed p-Akt levels in young
and old guts. Surprisingly, both p-Akt and total Akt levels are
slightly increased in aging intestines (Figure 4D). The age-related
increase in total Akt protein is accompanied by increases in akt
expression (Figure 4E), an activation that is likely driven by
Foxo, as akt has recently been described as a Foxo target
gene (Alic et al., 2011). These data suggest that the IIS pathway
is activated rather than repressed in older intestines and that
Foxo is activated by IIS-independent mechanisms.
Because high steady-state p-Akt levels may not reflect
changes in the sensitivity of the IIS pathway to extracellular
ligands, we also confirmed that the IIS pathway remains sensi-
tive to systemic insulin ligands in aging intestines. We performed
ex vivo insulin stimulation tests on young and old guts by
exposing dissected guts in culture media to mammalian insulin
and then measuring p-Akt levels. Insulin stimulation of both
young and aged intestines revealed a strong upregulation of
phosho-Akt, and older intestines appear to be even more sen-
sitive to this stimulation than young controls (Figure 4D). This
increased sensitivity is likely caused by the increased Akt and
InR expression levels.
Taken together, our data reveal that Foxo becomes chronically
activated in intestinal enterocytes with age, whereas the IIS
pathway appears to be active and hypersensitive. We propose
that this deregulation of IIS pathway control is at the center of
the metabolic dysfunction observed in aging flies.
Age-Related Changes in Intestinal JNK/Foxo Activity
Contribute to the Breakdown of Lipid Homeostasis
To identify alternative, IIS-independent, mechanisms respon-
sible for the age-related increase in Foxo activity, we turned to
JNK (Jun-N-terminal kinase), a stress-activated protein kinase
that can activate Foxo in both vertebrates and invertebrates.
JNK activity increases in older guts (Biteau et al., 2008), and
we thus hypothesized that this elevated JNK activity may be
responsible for the observed age-related increase in Foxo activ-Cell Reity and the subsequent breakdown of intestinal lipid metabolism.
Importantly, we confirmed that increased JNK activity in the
aging intestine, like Foxo, occurs primarily in enterocytes (as
determined using the JNK reporter puc-lacZ; Figure 5A). Inhibit-
ing JNK (using a dominant-negative form of the Drosophila JNK
basket [Bsk]) in intestinal enterocytes significantly blocked the
induction of thor-lacZ in aging guts (Figures 5B and 5B0), sug-
gesting that elevated JNK activity drives Foxo activation in the
aging intestine. We further found that acute JNK activation in
young guts is sufficient to repress intestinal lipase expression
in a Foxo-dependent manner: overexpression of a constitutively
active JNKK (hemipterous [Hep] inDrosophila) in intestinal enter-
ocytes induces thor expression (Figure S6) and also strongly re-
presses lipA/magro and CG6295 expression (Figure 5C). This
lipase repression is reduced in a Foxo mutant background
(Figure 5D). Importantly, the transcriptional downregulation of
intestinal lipases is not caused by JNK-mediated apoptosis of
enterocytes (Figure S4) as the same suppression was observed
in animals expressing the antiapoptotic molecule p35.
Supporting a role for chronic intestinal JNK/Foxo activation in
the age-related disruption of lipid homeostasis, we found that
reducing JNK activity (using UAS-BskDN) in enterocytes was
sufficient to prevent the age-associated repression of lipA/
magro and CG6295 (Figure 6A). Importantly, inhibiting intestinal
JNK activity also rescued the age-related reduction of lipid levels
in the whole organism (Figure 6B). These data support the notion
that JNK activation in enterocytes is a major contributor to the
overall breakdown of lipid homeostasis that occurs in the aging
fly. To further test this concept, we assayed starvation sensitivity
in the young and old flies described above. Aging flies are
more sensitive to starvation, which correlates with age-related
changes in glucose and lipid metabolism. Inhibiting JNK activa-
tion in enterocytes had no effect on starvation resistance in
young animals but led to significantly improved starvation resis-
tance in older flies (as compared to wild-type controls; Figures
6C and 6C0).
Together, these results suggest that JNK-mediated Foxo
activation (independent of IIS) in the aging intestine promotes
the deregulation of intestinal lipase expression and subsequent
disruption of intestinal and organismal lipid homeostasis in
Drosophila.
DISCUSSION
Our work identifies Foxo-mediated repression of intestinal
lipases as a critical component of an adaptive response to
dietary changes in Drosophila. Interestingly, misregulation of
this metabolic response also contributes to the age-associated
breakdown of lipid homeostasis, as elevated JNK signaling leads
to chronic Foxo activation and subsequent disruption of lipid
metabolism due to chronic repression of lipases. This age-
related deregulation of an adaptive metabolic response is remi-
niscent of insulin resistance-like phenotypes in vertebrates,
which can also be triggered by chronic activation of JNK
(Hirosumi et al., 2002; Samuel and Shulman, 2012), and thus
highlights the antagonistic pleiotropy inherent in metabolic regu-
lation. The adaptive nature of signaling interactions that drive
pathology (such as JNK-mediated insulin resistance) hasports 4, 1250–1261, September 26, 2013 ª2013 The Authors 1255
Figure 4. Increased Foxo Activation in the Aging Intestine
(A) Nuclear b-galactosidase (nls-lacZ) accumulates in old thor-lacZ intestines (35 days). Small panels show (at higher magnification) nls-lacZ is detected in large
enterocytes (white arrowheads) but not in intestinal stem cells (open arrowheads, cells marked by esg > GFP [green]). Genotype of fly: esgG4, UAS-GFP/thor-
lacZ; b-galactosidase (nls-lacZ; red); and DAPI (blue) detected by immunostaining. Images taken from posterior midgut (similar to the location of lipA/magro
expression; Figure S1A).
(B) Transcription of Foxo target genes thor, InR, and dlip4 in young (5–7 days) and old (35–45 days) wild-type (OreR female) intestines.
(C) Quantification of lacZ induction (X-gal staining of dissected intestines) in thor-lacZ/+ flies at various time points during aging. Bars represent percent of
intestines displaying X-gal staining in the posterior midgut, n = 15. Intestinal LacZ induction was scored independent of intensity.
(D and E) lipA/magro (D) and CG6295 (E) transcription (from dissected intestines) measured by qRT-PCR in young (5–7 days) and old (35 days) female flies in
which Foxo has been inhibited in enterocytes (NP1G4/UAS-FoxoRNAi compared to controls, NP1G4/+ [w1118]).
(F) Western blot analysis of p-Akt and total Akt (Akt) levels in dissected young (5–7 days) and old (35 days) wild-type intestines after ex vivo insulin stimulation.
Levels of b-actin serve as a loading control.
(G) Transcription of akt was measured by qRT-PCR from young and old wild-type intestines.
Bars represent mean ± SE and n = 4–8 samples.
See also Table S2.
1256 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The Authors
Figure 5. JNK-Dependent Foxo Activation in the Aging Intestine
(A) Nuclear b-galactosidase (nls-lacZ) accumulates in old puc-lacZ intestines
(35 days). Small panels show (at higher magnification) nls-lacZ is detected in
large enterocytes (white arrowheads) but not in intestinal stem cells (open
arrowheads, cellsmarked by esg >GFP [green]). Genotype of fly: esgG4, UAS-
GFP/+; puc-lacZ/+; b-galactosidase (nls-lacZ; red); and DAPI (blue) detected
by immunostaining. Images taken from posterior midgut (similar to the location
of lipA/magro expression; Figure S1A).
(B and B0 ) Expression of lacZ in the thor-lacZ line wasmonitored to detect Foxo
activation (X-gal staining of dissected intestines; image shows posterior
midgut) in young and old female flies (35 days) when JNK is inhibited in en-
terocytes (NP1G4, thor-lacZ; UAS-BskDN, compared to controls NP1G4, thor-
lacZ; +/+ [w1118]). X-gal intensity measurements represent mean ± SE of ten
(young) or 21 to 22 (old) guts.
(C) Attenuated lipA/magro and CG6295 transcription (measured by qRT-PCR
in dissected intestines) when JNK is conditionally overexpressed in intestinal
enterocytes (NP1G4,tubG80ts/UAS-HepACT compared to NP1G4,tubG80ts/+
Cell Reremained elusive in many instances, and our work provides a
model for age-related changes in an adaptive regulatory process
that ultimately lead to a pathological outcome. We believe that
this system can serve as a productive model to address a num-
ber of interesting questions with relevance to the loss of meta-
bolic homeostasis in aging organisms.
Systemic Control of Lipid Metabolism by JNK/Foxo
Interactions
In mammals, JNK has been shown to promote insulin resistance
both cell-autonomously and systemically (through inflamma-
tion), subsequently affecting lipid homeostasis in various
tissues (Samuel and Shulman, 2012). Our results further intro-
duce a mechanism by which JNK can alter cellular and sys-
temic lipid metabolism through the regulation of lipases,
independent of changes in IIS. Thus, JNK-mediated Foxo acti-
vation in select tissues may be able to alter intracellular lipid
metabolism, changing metabolic fuel substrates and disrupting
metabolic homeostasis in other tissues without altering insulin
responsiveness.
Whereas our data show that Foxo activation leads to the
transcriptional repression of intestinal lipases, especially LipA/
Magro, it remains unclear if this control is direct or indirect.
Foxo is classically described as an activator of transcription,
but recent reports have shown that Foxo can transcriptionally
repress genes through direct association with promoters (Alic
et al., 2011; Deng et al., 2012). The promoter regions of LipA/
Magro and CG6295 do not contain conserved Foxo transcription
factor binding sites, suggesting that the regulation of these
genes may be indirect, potentially through Foxo-regulated
expression of secondary effectors. Thus, tissue-specific control
of lipid homeostasis by IIS/Foxo might be achieved through the
regulation of lipogenic or lipolytic transcription factors that can
elicit global and direct changes in cellular lipid metabolism. Pre-
vious reports have shown that the nuclear receptor dHR96, a
critical regulator of lipid and cholesterol homeostasis, promotes
lipA/magro expression (Sieber and Thummel, 2009). However,
dhr96 expression is upregulated in aging intestines (data not
shown), suggesting that the age-related repression of intestinal
lipases is not merely due to decreases in dHR96 levels. dhr96
transcript levels are strongly induced in genetic conditions
where Foxo is activated and intestinal lipases are repressed
(data not shown), again suggesting that Foxo does not mediate
its effects on lipase transcription by antagonizing dhr96 exp-
ression. Furthermore, age-related changes that are independent
of JNK/Foxo activation may also contribute to the repression of
intestinal lipase expression and disruption of lipid metabolism,
such as an age-associated decline in feeding/food intake
(Wong et al., 2009).[w1118] controls). Five- to seven-day-old adult females were placed at 29C for
16 hr to induce conditional expression of UAS-HepACT.
(D) Inhibition of lipA/magro expression by enterocyte JNK activation is signif-
icantly rescued in a foxomutant background. Genotypes: (1) NP1G4, tubG80ts
(NP1, G80)/+ (w1118); (2) NP1, G80/+; foxoW24/foxoW24; (3) NP1, G80/UAS-
HepACT; and (4) NP1, G80/UAS-HepACT; foxoW24/foxoW24; samples collected
from whole flies.
Bars represent mean ± SE and n = 5 samples.
See also Figure S6 and Table S2.
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Figure 6. Age-Related Changes in Intestinal JNK Activity Contribute to the Disruption of Lipid Metabolism
(A) lipA/magro and CG6295 transcription (from dissected intestines) measured by qRT-PCR in young (5–7 days) and old (35 days) female flies in which JNK has
been inhibited in enterocytes (NP1G4/UAS-BskDN compared to controls, NP1G4/+ [w1118]).
(B) Whole animal TAG level measurements in young and old NP1G4/UAS-BskDN and NP1G4/+ (w1118) control female flies.
(C and C0 ) Increased starvation resistance in old flies (35 days, females) with JNK inhibition in intestinal enterocytes. Young (5–7 days) flies from independent
populations show no change in survival after starvation. Results are represented as percent survival (mean ± SE) after wet starvation of six cohorts of 18–20 flies
from individual populations.
Bars represent mean ± SE and n = 5–7 samples.
See also Table S2.Foxo-Mediated Disruption of Metabolic Homeostasis in
Drosophila
The reasons for the increase in JNK and Foxo activity in aging
ECs remain to be explored. Buchon et al. (2009) have also shown
that age-related activation of JNK in the intestinal epithelium is
dependent on the presence of commensal bacteria, asmaintain-
ing animals axenically reduces activation of JNK in the first
30 days of life. Thus, bacteria-induced inflammation and sub-
sequent JNK activation appears to be a likely cause, in part,
for age-related increases in Foxo activity. In a separate study,
however, we find that Foxo activation still occurs in intestines
of old (40-day-old), axenically reared flies, suggesting that age-
related activation of Foxo may also occur through JNK-indepen-
dent processes (L. Guo, J.K., S.Tran, and H.J., unpublished
data). Supporting this idea, our results show that inhibiting JNK
function in enterocytes can attenuate, although not completely
inhibit, this Foxo activation. Additional factors, such as sirtuins
or histone deacetylases, recently shown to deacetylate and acti-1258 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The Auvate Foxo in response to endocrine signals (Mihaylova et al.,
2011; Wang et al., 2011), may also lead to age-related increases
in intestinal Foxo activity.
Interactions between JNK and IIS/Foxo are mediated by
various mechanisms. In mammals, JNK phosphorylates the
insulin receptor substrate (IRS), inhibiting insulin signaling
transduction (Aguirre et al., 2000; Mamay et al., 2003). JNK
has also been shown to directly phosphorylate and activate
Foxo in mammalian cell culture (Essers et al., 2004). Whereas
JNK has clearly been shown to antagonize IIS (activate Foxo)
in C. elegans and Drosophila (Oh et al., 2005; Wang et al.,
2005), that exact mechanism by which Foxo activation is
achieved may be divergent in mammals. For example, no IRS
homolog has been identified in worms, and the JNK phosphory-
lation site in mammalian IRS is not conserved in flies. Our data
show that JNK-mediated Foxo activation in the aging fly intestine
is not achieved through IIS antagonism upstream of Akt, sug-
gesting either a direct interaction between Foxo and JNK orthors
changes in other regulators of Foxo. Recent studies have shown
that JNK-mediated phosphorylation of 14-3-3 proteins results in
the release of their binding partners, including Foxo (Sunayama
et al., 2005; Yoshida et al., 2005). The conservation of 14-3-3
proteins between vertebrates and invertebrates makes 14-3-3
an interesting candidate in promoting Foxo function via JNK in
the aging fly intestine (Nielsen et al., 2008). This chronic intestinal
Foxo activation and subsequent metabolic changes, provide a
physiological system in Drosophila to genetically dissect the
crosstalk between IIS/Foxo and JNK signaling. Detailed analysis
of these signaling interactions promises to provide important
insight into the pleiotropic effects of IIS/Foxo function and the
pathogenesis of age-related metabolic diseases.
Our data further reveal the pleiotropic consequences of Foxo
activation in regard to healthspan and longevity in Drosophila.
Overexpressing Foxo in the fat body or muscle of flies leads to
lifespan extension (Demontis and Perrimon, 2010; Giannakou
et al., 2004; Hwangbo et al., 2004). Conversely, we have recently
described that overexpression of Foxo in the intestinal stem cell
lineage shortens lifespan by inhibiting stem cell proliferation and
thus blocking proper tissue regeneration (Biteau et al., 2010).
Overexpression of selected cytoprotective Foxo target genes
in stem cells, on the other hand, is sufficient to prevent age-
associated dysplasia and extend lifespan (Biteau et al., 2010).
The data presented here show that chronic Foxo activation in
intestinal enterocytes disrupts lipid metabolism by deregulating
intestinal lipases and thus highlight how cell- and tissue-specific
consequences of Foxo function play an important role in
determining either the beneficial (i.e., lifespan extension) or
pathological (i.e., disruption of lipid metabolism) outcome of
Foxo activation.
Recent work in C. elegans has begun to explore the relation-
ship between lipid metabolism and longevity, revealing that
increases in intestinal lipase expression can extend lifespan
(O’Rourke et al., 2013; Wang et al., 2008). The beneficial effects
of elevated lipase expression appear to be mediated by in-
creases in specific types of fatty acids, which can activate
autophagy and lead to lifespan extension (O’Rourke et al.,
2013). Interventions that promote lipid homeostasis with age,
such as JNK/Foxo inhibition in intestinal enterocytes, might
thus affect healthspan and/or longevity through means other
than primarily maintaining energy homeostasis.
EXPERIMENTAL PROCEDURES
Drosophila Stocks and Culture
The following strains were obtained from the Bloomington Drosophila
Stock Center: OreR; w1118; y1w1; thor-lacZ; UAS-p35; and tub-Gal80ts. UAS-
FoxoRNAi was obtained from the Vienna Drosophila RNAi Center (transformant
ID 106097). NP1Gal4 was kindly provided by D. Ferrandon; UAS-Magro by
C.Thummel; the foxoW24 mutant allele by M.Tatar; the foxoD94 allele by L. Par-
tridge; GMRGal4, UAS-HepACT, and UAS-BskDN by M. Mlodzik; esg-Gal4 and
esg-LacZC4-1 by S. Hayashi; Su(H)-GBE-lacZ by S. Bray; and puc-lacZ
(pucE69) by E. Martı´n-Blanco. UAS-Foxo was previously described in Puig
et al. (2003). For aging and starvation sensitivity experiments, UAS-FoxoRNAi,
UAS-BskDN, UAS-Magro, and UAS-Foxo transgenic lines were backcrossed
8–10 generations into the w1118 background. Backcrossed UAS flies and
w1118male siblings were used to set up the crosses in order to reduce genetic
background effects. The foxoW24 mutant was backcrossed into the yw back-
ground, and yw siblings were used as controls (Figure 1E).Cell ReAll flies were raised on standard yeast- and molasses-based food at 25C
and 65% humidity on a 12 hr light/dark cycle, unless otherwise indicated.
Food for HSLY diet feeding (and St. SY control food) was made with the
following protocol (as described in Skorupa et al. [2008]): HSLY, 1.5 g agar/
40 g sucrose/2.5 g yeast (yeast flake)/0.3 ml propionic acid/100 ml water
and St. SY, 1.5 g agar/10 g sucrose/10 g yeast/0.3 ml propionic acid/100 ml
water. Ingredients were combined, heated to at least 120C, and cooled
before pouring.
Analysis of Gene Expression
Total RNA from eight to ten guts or from five whole flies (without heads) was
extracted using Trizol and complementary DNA synthesized using Superscript
II (Invitrogen). Real-time PCR was performed using SyberGreen, a Biorad IQ5
apparatus, and the primers pairs described in the Extended Experimental Pro-
cedures (Table S2). Results are average ± standard error of at least three inde-
pendent samples, and quantification of gene expression levels weremeasured
relative to the expression of Actin5c.
Western Blot Analysis
Guts (10–20) were homogenized in protein sample buffer; proteins were
separated by SDS-PAGE and transferred to nitrocellulose membrane using
standard procedures. The following antibodies (all from Cell Signaling)
were used: phospho-Akt (anti-p-Drosophila Akt [S505]; rabbit, 1:1,000), total
Akt (anti-pan Akt; rabbit, 1:1,000), and b-actin (anti-beta-actin; rabbit,
1:5,000). Signal was detected using horseradish peroxidase-conjugated
anti-rabbit and chemiluminescence (Pierce) according to manufacturer
instructions.
Detection of b-Galactosidase Activity
Intact guts were dissected in PBS + 2 mMMgCl2 and fixed for 10 min in 0.5%
glutaraldehyde. Detection of b-galactosidase activity was carried out at room
temperature in staining buffer (PBS, 2 mM MgCl2, 5 mM K4(Fe[CN]6), 5 mM
K3(Fe[CN]6), 0.1% X-gal).
Metabolite Measurements
For TAG assays, four to five females (without the head) were homogenized in
150 ml of PBST (PBS, 0.1% Tween 20) heated at 70C to inactivate endoge-
nous enzymes (homogenate cleared by centrifugation). Thirty microliters of
cleared extract was used to measure triglycerides concentrations according
to the manufacturer instructions (StanBio Liquicolor Triglycerides). TAG levels
were normalized to weight (measured using MT XS64 scale).
Oil Red O Staining
Guts were dissected in PBS and fixed in 4% formaldehyde/PBS for 20 min.
Guts were then washed twice with PBS, incubated for 30 min in fresh Oil
Red O solution (6 ml of 0.1%Oil Red O in isopropanol and 4 ml diethylpyrocar-
bonate water, and passed through a 0.45 mm syringe), followed by rinsing with
distilled water.
Immunostaining and Microscopy
Intact guts were fixed at room temperature for 45min in 100mMglutamic acid,
25 mM KCl, 20 mM MgSO4, 4 mM sodium phosphate, 1 mM MgCl2, and 4%
formaldehyde. All subsequent incubations were done in PBS, 0.5% BSA,
and 0.1% Triton X-100 at 4C.
The following primary antibodies were used: mouse anti-b-Gal (1:200),
mouse anti-Prospero (1:250), and mouse anti-armadillo (1:100) from De-
velopmental Studies Hybridoma Bank. Fluorescent secondary antibodies
were obtained from Jackson Immunoresearch. Hoechst was used to
stain DNA.
Confocal images were collected using a Leica SP5 confocal system and
processed using the Leica software and Adobe Photoshop.
Ex Vivo Insulin Stimulation
Guts (8–10) were dissected in PBS and then transferred to M3+BPYE (without
serum) cell culture media with or without bovine insulin (0.1 units per 40 ml
media from Sigma) for 20 min. Samples were then prepared for protein extrac-
tion/western blot analysis, as previously described.ports 4, 1250–1261, September 26, 2013 ª2013 The Authors 1259
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2013.08.004.
ACKNOWLEDGMENTS
This work was supported by the National Institute on Aging (NIH RO1
AG028127 to H.J.) and an AFAR/Ellison postdoctoral fellowship (to J.K.).
Received: February 28, 2013
Revised: July 16, 2013
Accepted: August 2, 2013
Published: September 12, 2013
REFERENCES
Accili, D., and Arden, K.C. (2004). FoxOs at the crossroads of cellular meta-
bolism, differentiation, and transformation. Cell 117, 421–426.
Aguirre, V., Uchida, T., Yenush, L., Davis, R., andWhite, M.F. (2000). The c-Jun
NH(2)-terminal kinase promotes insulin resistance during association with
insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem.
275, 9047–9054.
Alic, N., Andrews, T.D., Giannakou, M.E., Papatheodorou, I., Slack, C., Hoddi-
nott, M.P., Cocheme´, H.M., Schuster, E.F., Thornton, J.M., and Partridge, L.
(2011). Genome-wide dFOXO targets and topology of the transcriptomic
response to stress and insulin signalling. Mol. Syst. Biol. 7, 502.
Badin, P.M., Louche, K., Mairal, A., Liebisch, G., Schmitz, G., Rustan, A.C.,
Smith, S.R., Langin, D., and Moro, C. (2011). Altered skeletal muscle lipase
expression and activity contribute to insulin resistance in humans. Diabetes
60, 1734–1742.
Barzilai, N., Huffman, D.M., Muzumdar, R.H., and Bartke, A. (2012). The critical
role of metabolic pathways in aging. Diabetes 61, 1315–1322.
Baumeister, R., Schaffitzel, E., and Hertweck,M. (2006). Endocrine signaling in
Caenorhabditis elegans controls stress response and longevity. J. Endocrinol.
190, 191–202.
Biteau, B., Hochmuth, C.E., and Jasper, H. (2008). JNK activity in somatic
stem cells causes loss of tissue homeostasis in the aging Drosophila gut.
Cell Stem Cell 3, 442–455.
Biteau, B., Karpac, J., Supoyo, S., Degennaro, M., Lehmann, R., and Jasper,
H. (2010). Lifespan extension by preserving proliferative homeostasis in
Drosophila. PLoS Genet. 6, e1001159.
Biteau, B., Hochmuth, C.E., and Jasper, H. (2011a). Maintaining tissue homeo-
stasis: dynamic control of somatic stem cell activity. Cell StemCell 9, 402–411.
Biteau, B., Karpac, J., Hwangbo, D., and Jasper, H. (2011b). Regulation of
Drosophila lifespan by JNK signaling. Exp. Gerontol. 46, 349–354.
Blu¨her, M., Kahn, B.B., and Kahn, C.R. (2003). Extended longevity inmice lack-
ing the insulin receptor in adipose tissue. Science 299, 572–574.
Buchon, N., Broderick, N.A., Chakrabarti, S., and Lemaitre, B. (2009). Invasive
and indigenous microbiota impact intestinal stem cell activity through multiple
pathways in Drosophila. Genes Dev. 23, 2333–2344.
Calnan, D.R., and Brunet, A. (2008). The FoxO code. Oncogene 27, 2276–
2288.
Chakrabarti, P., and Kandror, K.V. (2009). FoxO1 controls insulin-dependent
adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes.
J. Biol. Chem. 284, 13296–13300.
Choi, N.H., Kim, J.G., Yang, D.J., Kim, Y.S., and Yoo, M.A. (2008). Age-related
changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like
growth factor. Aging Cell 7, 318–334.
Demontis, F., and Perrimon, N. (2010). FOXO/4E-BP signaling in
Drosophila muscles regulates organism-wide proteostasis during aging.
Cell 143, 813–825.1260 Cell Reports 4, 1250–1261, September 26, 2013 ª2013 The AuDeng, X., Zhang, W., O-Sullivan, I., Williams, J.B., Dong, Q., Park, E.A.,
Raghow, R., Unterman, T.G., and Elam, M.B. (2012). FoxO1 inhibits sterol
regulatory element-binding protein-1c (SREBP-1c) gene expression via tran-
scription factors Sp1 and SREBP-1c. J. Biol. Chem. 287, 20132–20143.
Eijkelenboom, A., and Burgering, B.M. (2013). FOXOs: signalling integrators
for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83–97.
Essers, M.A., Weijzen, S., de Vries-Smits, A.M., Saarloos, I., de Ruiter, N.D.,
Bos, J.L., and Burgering, B.M. (2004). FOXO transcription factor activation
by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J.
23, 4802–4812.
Garofalo, R.S. (2002). Genetic analysis of insulin signaling in Drosophila.
Trends Endocrinol. Metab. 13, 156–162.
Ge´minard, C., Rulifson, E.J., and Le´opold, P. (2009). Remote control of insulin
secretion by fat cells in Drosophila. Cell Metab. 10, 199–207.
Giannakou, M.E., Goss, M., Ju¨nger, M.A., Hafen, E., Leevers, S.J., and Par-
tridge, L. (2004). Long-lived Drosophila with overexpressed dFOXO in adult
fat body. Science 305, 361.
Hirosumi, J., Tuncman, G., Chang, L., Go¨rgu¨n, C.Z., Uysal, K.T., Maeda, K.,
Karin, M., and Hotamisligil, G.S. (2002). A central role for JNK in obesity and
insulin resistance. Nature 420, 333–336.
Hwangbo, D.S., Gershman, B., Tu, M.P., Palmer, M., and Tatar, M. (2004).
Drosophila dFOXO controls lifespan and regulates insulin signalling in brain
and fat body. Nature 429, 562–566.
Karpac, J., and Jasper, H. (2009). Insulin and JNK: optimizing metabolic
homeostasis and lifespan. Trends Endocrinol. Metab. 20, 100–106.
Karpac, J., Hull-Thompson, J., Falleur, M., and Jasper, H. (2009). JNK
signaling in insulin-producing cells is required for adaptive responses to stress
in Drosophila. Aging Cell 8, 288–295.
Karpac, J., Younger, A., and Jasper, H. (2011). Dynamic coordination of innate
immune signaling and insulin signaling regulates systemic responses to local-
ized DNA damage. Dev. Cell 20, 841–854.
Kido, Y., Burks, D.J., Withers, D., Bruning, J.C., Kahn, C.R., White, M.F., and
Accili, D. (2000). Tissue-specific insulin resistance inmice withmutations in the
insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105, 199–205.
Kitamura, T., Kahn, C.R., and Accili, D. (2003). Insulin receptor knockout mice.
Annu. Rev. Physiol. 65, 313–332.
Libina, N., Berman, J.R., and Kenyon, C. (2003). Tissue-specific activities of C.
elegans DAF-16 in the regulation of lifespan. Cell 115, 489–502.
Lin, K., Dorman, J.B., Rodan, A., and Kenyon, C. (1997). daf-16: An HNF-3/
forkhead family member that can function to double the life-span of Caeno-
rhabditis elegans. Science 278, 1319–1322.
Lowe, M.E. (2000). Properties and function of pancreatic lipase related protein
2. Biochimie 82, 997–1004.
Luca, F., Perry, G.H., and Di Rienzo, A. (2010). Evolutionary adaptations to
dietary changes. Annu. Rev. Nutr. 30, 291–314.
Luo, X., Puig, O., Hyun, J., Bohmann, D., and Jasper, H. (2007). Foxo and Fos
regulate the decision between cell death and survival in response to UV irradi-
ation. EMBO J. 26, 380–390.
Mamay, C.L., Mingo-Sion, A.M., Wolf, D.M., Molina, M.D., and Van Den Berg,
C.L. (2003). An inhibitory function for JNK in the regulation of IGF-I signaling in
breast cancer. Oncogene 22, 602–614.
Matsumoto, M., and Accili, D. (2005). All roads lead to FoxO. Cell Metab. 1,
215–216.
Micchelli, C.A., and Perrimon, N. (2006). Evidence that stem cells reside in the
adult Drosophila midgut epithelium. Nature 439, 475–479.
Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnu-
son,M.A., and Kahn, C.R. (2000). Loss of insulin signaling in hepatocytes leads
to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6,
87–97.
Mihaylova, M.M., Vasquez, D.S., Ravnskjaer, K., Denechaud, P.D., Yu, R.T.,
Alvarez, J.G., Downes, M., Evans, R.M., Montminy, M., and Shaw, R.J.thors
(2011). Class IIa histone deacetylases are hormone-activated regulators of
FOXO and mammalian glucose homeostasis. Cell 145, 607–621.
Niedernhofer, L.J., Garinis, G.A., Raams, A., Lalai, A.S., Robinson, A.R.,
Appeldoorn, E., Odijk, H., Oostendorp, R., Ahmad, A., van Leeuwen, W.,
et al. (2006). A new progeroid syndrome reveals that genotoxic stress sup-
presses the somatotroph axis. Nature 444, 1038–1043.
Nielsen, M.D., Luo, X., Biteau, B., Syverson, K., and Jasper, H. (2008). 14-3-3
Epsilon antagonizes FoxO to control growth, apoptosis and longevity in
Drosophila. Aging Cell 7, 688–699.
O’Rourke, E.J., Kuballa, P., Xavier, R., and Ruvkun, G. (2013). u-6 Polyunsat-
urated fatty acids extend life span through the activation of autophagy. Genes
Dev. 27, 429–440.
Odegaard, J.I., and Chawla, A. (2013). Pleiotropic actions of insulin resistance
and inflammation in metabolic homeostasis. Science 339, 172–177.
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G.I., Lee, L., Tissenbaum, H.A.,
and Ruvkun, G. (1997). The Fork head transcription factor DAF-16 transduces
insulin-likemetabolic and longevity signals in C. elegans. Nature 389, 994–999.
Oh, S.W., Mukhopadhyay, A., Svrzikapa, N., Jiang, F., Davis, R.J., and Tissen-
baum, H.A. (2005). JNK regulates lifespan in Caenorhabditis elegans bymodu-
lating nuclear translocation of forkhead transcription factor/DAF-16. Proc.
Natl. Acad. Sci. USA 102, 4494–4499.
Ohlstein, B., and Spradling, A. (2006). The adult Drosophila posterior midgut is
maintained by pluripotent stem cells. Nature 439, 470–474.
Oldham, S., and Hafen, E. (2003). Insulin/IGF and target of rapamycin
signaling: a TOR de force in growth control. Trends Cell Biol. 13, 79–85.
Osterwalder, T., Yoon, K.S., White, B.H., and Keshishian, H. (2001). A condi-
tional tissue-specific transgene expression system using inducible GAL4.
Proc. Natl. Acad. Sci. USA 98, 12596–12601.
Puig, O., Marr, M.T., Ruhf, M.L., and Tjian, R. (2003). Control of cell number by
Drosophila FOXO: downstream and feedback regulation of the insulin receptor
pathway. Genes Dev. 17, 2006–2020.
Rera, M., Clark, R.I., and Walker, D.W. (2012). Intestinal barrier dysfunction
links metabolic and inflammatory markers of aging to death in Drosophila.
Proc. Natl. Acad. Sci. USA 109, 21528–21533.
Rera, M., Azizi, M.J., andWalker, D.W. (2013). Organ-specificmediation of life-
span extension: more than a gut feeling? Ageing Res. Rev. 12, 436–444.
Roberts, S.B., and Rosenberg, I. (2006). Nutrition and aging: changes in the
regulation of energy metabolism with aging. Physiol. Rev. 86, 651–667.
Rulifson, E.J., Kim, S.K., and Nusse, R. (2002). Ablation of insulin-producing
neurons in flies: growth and diabetic phenotypes. Science 296, 1118–1120.
Saltiel, A.R., and Kahn, C.R. (2001). Insulin signalling and the regulation of
glucose and lipid metabolism. Nature 414, 799–806.
Samuel, V.T., and Shulman, G.I. (2012). Mechanisms for insulin resistance:
common threads and missing links. Cell 148, 852–871.
Schoenborn, V., Heid, I.M., Vollmert, C., Lingenhel, A., Adams, T.D., Hopkins,
P.N., Illig, T., Zimmermann, R., Zechner, R., Hunt, S.C., and Kronenberg, F.
(2006). The ATGL gene is associated with free fatty acids, triglycerides, and
type 2 diabetes. Diabetes 55, 1270–1275.
Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S., and
Goldstein, J.L. (2000). Decreased IRS-2 and increased SREBP-1c lead to
mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob
mice. Mol. Cell 6, 77–86.Cell ReSieber, M.H., and Thummel, C.S. (2009). The DHR96 nuclear receptor controls
triacylglycerol homeostasis in Drosophila. Cell Metab. 10, 481–490.
Sieber, M.H., and Thummel, C.S. (2012). Coordination of triacylglycerol and
cholesterol homeostasis by DHR96 and the Drosophila LipA homolog magro.
Cell Metab. 15, 122–127.
Skorupa, D.A., Dervisefendic, A., Zwiener, J., and Pletcher, S.D. (2008). Die-
tary composition specifies consumption, obesity, and lifespan in Drosophila
melanogaster. Aging Cell 7, 478–490.
Slack, C., Giannakou, M.E., Foley, A., Goss, M., and Partridge, L. (2011).
dFOXO-independent effects of reduced insulin-like signaling in Drosophila.
Aging Cell 10, 735–748.
Sunayama, J., Tsuruta, F., Masuyama, N., and Gotoh, Y. (2005). JNK antago-
nizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol.
170, 295–304.
Suzuki, R., Lee, K., Jing, E., Biddinger, S.B., McDonald, J.G., Montine, T.J.,
Craft, S., and Kahn, C.R. (2010). Diabetes and insulin in regulation of brain
cholesterol metabolism. Cell Metab. 12, 567–579.
Taguchi, A., and White, M.F. (2008). Insulin-like signaling, nutrient homeosta-
sis, and life span. Annu. Rev. Physiol. 70, 191–212.
Tatar, M., Bartke, A., and Antebi, A. (2003). The endocrine regulation of aging
by insulin-like signals. Science 299, 1346–1351.
Teleman, A.A. (2010). Molecular mechanisms ofmetabolic regulation by insulin
in Drosophila. Biochem. J. 425, 13–26.
van der Pluijm, I., Garinis, G.A., Brandt, R.M., Gorgels, T.G., Wijnhoven, S.W.,
Diderich, K.E., de Wit, J., Mitchell, J.R., van Oostrom, C., Beems, R., et al.
(2007). Impaired genome maintenance suppresses the growth hormone—in-
sulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol.
5, e2.
Vihervaara, T., and Puig, O. (2008). dFOXO regulates transcription of a
Drosophila acid lipase. J. Mol. Biol. 376, 1215–1223.
Wang, M.C., Bohmann, D., and Jasper, H. (2005). JNK extends life span and
limits growth by antagonizing cellular and organism-wide responses to insulin
signaling. Cell 121, 115–125.
Wang, M.C., O’Rourke, E.J., and Ruvkun, G. (2008). Fat metabolism links
germline stem cells and longevity in C. elegans. Science 322, 957–960.
Wang, B., Moya, N., Niessen, S., Hoover, H., Mihaylova, M.M., Shaw, R.J.,
Yates, J.R., 3rd, Fischer, W.H., Thomas, J.B., and Montminy, M. (2011). A hor-
mone-dependent module regulating energy balance. Cell 145, 596–606.
Wong, R., Piper, M.D., Wertheim, B., and Partridge, L. (2009). Quantification of
food intake in Drosophila. PLoS ONE 4, e6063.
Xu, X., Gopalacharyulu, P., Seppa¨nen-Laakso, T., Ruskeepa¨a¨, A.L., Aye, C.C.,
Carson, B.P., Mora, S., Oresic, M., and Teleman, A.A. (2012). Insulin signaling
regulates fatty acid catabolism at the level of CoA activation. PLoS Genet. 8,
e1002478.
Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D., and Miki, Y. (2005). JNK
phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the
apoptotic response to DNA damage. Nat. Cell Biol. 7, 278–285.
Zhang, P., Judy, M., Lee, S.J., and Kenyon, C. (2013). Direct and indirect gene
regulation by a life-extending FOXO protein in C. elegans: roles for GATA fac-
tors and lipid gene regulators. Cell Metab. 17, 85–100.ports 4, 1250–1261, September 26, 2013 ª2013 The Authors 1261
